Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Author:
Vieira-Silva SaraORCID, , Falony Gwen, Belda Eugeni, Nielsen TrineORCID, Aron-Wisnewsky Judith, Chakaroun Rima, Forslund Sofia K., Assmann Karen, Valles-Colomer Mireia, Nguyen Thi Thuy Duyen, Proost SebastianORCID, Prifti EdiORCID, Tremaroli Valentina, Pons Nicolas, Le Chatelier Emmanuelle, Andreelli Fabrizio, Bastard Jean-Phillippe, Coelho Luis PedroORCID, Galleron Nathalie, Hansen Tue H., Hulot Jean-Sébastien, Lewinter Christian, Pedersen Helle K., Quinquis Benoit, Rouault Christine, Roume Hugo, Salem Joe-Elie, Søndertoft Nadja B.ORCID, Touch Sothea, Dumas Marc-EmmanuelORCID, Ehrlich Stanislav DuskoORCID, Galan PilarORCID, Gøtze Jens P., Hansen TorbenORCID, Holst Jens J.ORCID, Køber Lars, Letunic IvicaORCID, Nielsen JensORCID, Oppert Jean-Michel, Stumvoll Michael, Vestergaard HenrikORCID, Zucker Jean-Daniel, Bork PeerORCID, Pedersen OlufORCID, Bäckhed Fredrik, Clément KarineORCID, Raes JeroenORCID
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference54 articles.
1. Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017). 2. Vieira-Silva, S. et al. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses. Nat. Microbiol. 4, 1826–1831 (2019). 3. Probert, C. S., Emmett, P. M. & Heaton, K. W. Some determinants of whole-gut transit time: a population-based study. QJM 88, 311–315 (1995). 4. Ford, E. S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22, 1971–1977 (1999). 5. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
Cited by
319 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|